Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Cell Reports|September 24, 2013
Characterization and analysis of the composition and dynamics of the mammalian riboproteomeMarkus Reschke, John G Clohessy, Nina Seitzer, et al.
Molecular Cancer Therapeutics|May 14, 2017
Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53-Deficient Prostate Cancer to RadiationAnne L van de Ven, Shifalika Tangutoori, Paige Baldwin, et al.
Biomedicines|May 27, 2023
Targeting of microRNA-22 Suppresses Tumor Spread in a Mouse Model of Triple-Negative Breast CancerRiccardo Panella, Cody A Cotton, Valerie A Maymi, et al.
Experimental Hematology|November 5, 2013
NPMc+ cooperates with Flt3/ITD mutations to cause acute leukemia recapitulating human diseaseRachel Rau, Daniel Magoon, Sarah Greenblatt, et al.
Nature Medicine|January 9, 2018
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanismsMarco Bezzi, Nina Seitzer, Tomoki Ishikawa, et al.
Nature Genetics|April 20, 2010
Subtle variations in Pten dose determine cancer susceptibilityAndrea Alimonti, Arkaitz Carracedo, John G Clohessy, et al.
Science Signaling|January 30, 2009
Differential requirement of mTOR in postmitotic tissues and tumorigenesisCaterina Nardella, Arkaitz Carracedo, Andrea Alimonti, et al.
Nature Methods|March 2, 2021
Dual DNA and protein tagging of open chromatin unveils dynamics of epigenomic landscapes in leukemiaJonathan D Lee, Joao A Paulo, Ryan R Posey, et al.
The Journal of Clinical Investigation|March 4, 2010
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesisAndrea Alimonti, Caterina Nardella, Zhenbang Chen, et al.
Cell|April 21, 2018
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug ResistanceAssaf C Bester, Jonathan D Lee, Alejandro Chavez, et al.
Pageof 6